Monoclonal Antibody Therapy (mAb) for COVID-19
Check if you’re eligible for at-home mAbs
Monoclonal antibody treatment can reduce the risk of severe illness and hospitalization when you test positive for COVID-19. American Infusion’s skilled team offers mAb therapy in the convenience of your home or LTC facility.
Currently servicing parts of:
New York, New Jersey, Pennsylvania, Maryland and Ohio
Find out more about mAbs for your facility
FDA-authorized
Monoclonal antibody therapy is for emergency use in individuals with high-risk COVID factors or in danger of developing severe illness.
Convenient At-Home Treatment
We offer monoclonal antibody therapy and treatment systems direct to your home or long-term care facility, administered by American Infusion trained nursing staff.
No Out Pocket Cost
mAbs treatment is fully covered by insurance or federal uninsured funds, with zero out-of-pocket fees.
How can we help you combat COVID-19?
mAbs for At-Home Treatment
Protect yourself and your loved ones from severe illness and hospitalizations due to COVID-19. If you tested positive for COVID, you may be eligible for safe and effective mAb treatment in the convenience of your home.
mAbs for Long-Term Care Facilities
Protect your residents from severe illness and hospitalization with mAb therapy. A resident who tests positive for COVID-19 is likely eligible for mAbs therapy treatment.
mAbs are administered directly after exposure to COVID-19 when you test positive, or up to 10 days after onset of symptoms.
70%-85% Reduction In Hospitalizations
Monoclonal antibody therapy reduces the chance of severe illness, hospitalization and patient fatalities.
80% Reduction In Spread
mAbs treatment reduces the spread of COVID-19 and infection among patients’ households.
We’re Hiring!
Protect your family. Protect your residents.
Check if you’re eligible for at-home mAbs
Find out more about mAbs for your facility
